Personalized Dosing via Salivary and Dried Blood Spot Testing
A hallmark of BHRT in 2026 is Precision Diagnostics. Rather than a "one-size-fits-all" pill, therapy is based on a patient’s unique hormonal fluctuations.
Clinicians use multi-point testing (saliva or dried blood spots) to map the "Diurnal Rhythm" of hormones. This data allows for the creation of a personalized hormone profile. In 2026, AI algorithms analyze these profiles to suggest specific dose adjustments, ensuring the patient stays within the "optimal physiological window" rather than just the "normal range," which is often too broad for symptom relief.
2 Views